A randomised vehicle controlled multicenter dose finding phase. II. Study of glycosylated rhuG-CSF in 121 patients after bone marrow transplantation.
Scarffe
J H
JH
Cancer Research Department of Medical Oncology, Christie Hospital NHS Trust, Withington, Manchester, UK.
D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006031:Glycosylation; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology; D014677:Pharmaceutical Vehicles / Q000008:administration & dosage; D011994:Recombinant Proteins / Q000008:administration & dosage
D014677:Pharmaceutical Vehicles; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor